We describe a gas-chromatographic micromethod, with use of a solid injection system and an electron capture detector, for determination of underivatized clonazepam in serum. Vigorous mixing of 100 l of serum with 20 zl of borate buffer (pH 9.0) and 100 l of a cyclohexane/ 
Improved Micromethod for Determination of Underivatized

Clonazepam in Serum by Gas Chromatography Peter M. Edeibroek and Frederik A. De Wolff
We describe a gas-chromatographic micromethod, with use of a solid injection system and an electron capture detector, for determination of underivatized clonazepam in serum. Vigorous mixing of 100 l of serum with 20 zl of borate buffer (pH 9.0) and 100 l of a cyclohexane/ (Figure 1 ) is clinically effective in the treatment of various types of epilepsy (1) (2) (3) . For the quantitation of clonazepam, thin-layer chromatographic (4), gas-chromatographic (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) , radiometric (15), radioimmunoasaay (16, 17) and high-performance liquid chromatographic (18, 19) methods have been described. Most of the gas-chromatographic assays are based on indirect determination of clonazepam, after hydrolysis, as 2-amino-5-nitro-2'-chlorobenzophenone (5-9), or, after alkylation, as its alkylated derivative (10, 11) . Although a determination of clonazepam as the intact drug (5) proved unfeasible in the hands of Knop et al. (7), Gerna and Morselli (13) described such a method. De Boer et al. (14) developed an assayprocedure for underivatized nitrazepam and clonazepam in plasma, using gas chromatography with a support-coated open tubular column. Nitrazepam is used as internal standard in the assay of clonazepam, and vice versa.
Our purpose was to develop a simpler and faster determination of clonazepam, suitable for clinical routine and sufficiently specific in relation to the common co-medication. 
Materials and Methods
Chemicals
All chemicals were of analytical grade. Dichloromethane, cyclohexane, sodium bicarbonate, orthoboric acid, and potassium chloride were purchased from Merck.
H3BO3-Na2CO3-KC1 buffer solution (1 mol/liter, pH 9.0) was prepared as described elsewhere (20) .
Stock solutions of clonazepam and methyl nitrazepam (kindly supplied by Hoffmann-La Roche, Mijdrecht, The Netherlands) were prepared in ethanol to give a concentration of 1 g/ liter for each compound. Serum standards of 5, 10, 25, 50, 75, 100,and 150 iig clonazepam per liter were prepared by adding exact volumes of a standard solution of 40 mg/liter clonazepam to drug-free pooledserum.Serum standards were divided into 100-d samples, transferred to Teflon-lined screw-capped conical tubes, and frozen at -20 #{176}C.
Glassware
All glassware was washed with laboratory detergent (Liquinox; Alconox Inc., New York, N.Y. 10003), cleaned with dichromate-sulfuric acid, rinsed with tap and bi-distilled water successively, and dried.
Apparatus
We used a gas chromatograph (Packard-Becker, Model 419) equipped with a 63Ni electron capture detector and linearizer Model 736. The solid injection system was a pyrolysis system [Becker, Model 767, modified according to Driessen and Emonds (21)1. A 0.60-m glass column (1.2mm i.d.) was packed with 3% OV-17 on Supelcoport 210-250 im (60-70 mesh). This column was conditioned overnight at 255 #{176}C with a carrier gas (N2) flow of 7 mi/mm. The analysis was carried out isothermally with the oven temperature at 245 #{176}C, the injection port kept at 305 #{176}C, and the detector at 345 #{176}C. Carrier gas flow rate was 7 ml/min and the detector purge (N2) 25 ml/min. The chromatogram was registered on a flat-bed recorder (Packard, Model 610) at a chart speed of 1 cm/mm.
Patients'Sera
Bloodfrom patients receiving oral therapy with clonazepam was drawn just before the first morning dose. Serum was separated as soon as possible, immediately frozen to prevent decomposition of clonazepam (7), and stored at -20 #{176}C until analyzed.
Procedure
To 100 idof serum (standard or patient) in conical tubes (10 ml, 10 x 110 mm) provided with Teflon-lined screw-caps, add with an automatic pipettor (Clinipett, Labora Mannheim) 20 Ml of borate buffer (pH 9.0) and 100 sl of a cyclohexane/dichloromethane mixture (4/6 by vol)containing 50.0 ig of methyl nitrazepani (internal standard) per liter. Afterthorough vortex-mixing for 30s, centrifuge thetubesat3000rpm for 2 mm. Pass the needle of a 10-id gas-chromatographic syringe through the aqueous (upper) phase and the precipitated protein interface into the organic phase and aspirate 10 is! ofthe extract into the syringe. Wipe theneedlewith a tissue, and transfer the solutionvia the needle of the solidgaschromatographic injection system. Afterevaporation of the solvent, inject for 15 s.
Repeat some injections ofextracts ofblank serum before analysis, to obtain peaks that are more gaussian. 
Results and Discussion
The micro-extraction procedure is a modification of the procedure of Flanagan and Berry (22) of clonazepam, becauseit is not used as a drug and its structure is comparable with that of clonazepam ( Figure 1) .
We 
For patients on chronic oral treatment with clonazepam in the range of 0.33 to 14 mg daily, steady-state concentrations of 0.1-104 sg of clonazepam per liter are mentioned in the literature (1,2, 7) . In a series of 28 patients with a clonazepam dosage range of 0.3-10 mg per day, we measured concentrations in serum of 5-97 g of clonazepam per liter, regardless of the co-medication. Although in this group there was a highly linear relationship (Figure 3 ) between clonazepam dosage (in mg/kg body weight) and the concentration of clonazepam (in isg/liter), we believe it is not useful to define these data statistically, because there are still so many uncontrolled parameters. From the present observations we estimate the therapeutic concentrations for the control of seizures at between 10 and 60 isg/liter of serum, which is in good agreement with the experiences of Nanda et al. (2) .
____________In principle, our assay procedure can also be used to de- (7) with a good recovery from plasma in the pH range of 3-10. We chose pH 9.0, but we found no significant difference in accuracy or intraday precision when we extracted at pH 4.0. A second sample from the same tube gave results similar to those for the first sample, We found thatthe variation can mainly be attributed to pipetting error.
The lowest amount detectable by the method, determined as the concentration of clonazepam necessary to produce a signal twice as large as the value of the background noise, is bout 1 gfliter.
The combination of a short, semi-capillary column with the solid injection system makes it possible to obtain peaks with a minimum of tailing at a relatively low oven temperature. The chromatograms in Figure 2 show the satisfactory properties of our column in analysis for clonazepam. Peaks due to extractable serum compounds, components of the 0-rings of the solid injection system, and/or impurities of reagents give no interference in analyses. There is sufficient difference in retention time between clonazepam and its relevant metabolites, 7-amino clonazepam, 7-acetamido clonazepam, and 3-hydroxy clonazepam. Except in the plasma of patients with a highclonazepam concentration, the pharmacologically active metabolite, 3-hydroxy clonazepam, was known to be present in very low concentrations or absent (7) .
Other anticonvulsant drugs, such as sodium valproate, primidone, phenytoin, phenobarbital, ethosuximide, and carbamazepine and their metabolites, do not interfere in the clonazepam procedure. Knop et al. (7) described interference caused by an unidentified metabolite or fragment of carbamazepine in the plasma of patients receiving carbamazepine co-medication. In the serum of patients with carbamazepine co-medication we also often observed unknown peaks. Since, as Figure 2D shows, the last peak of this series can easily interfere with the clonazepam peak, a column with sufficient resolving power is required. This interference increases as the column ages, because the retention time of clonazepam relative to methyl nitrazepam is decreased.
Related compounds, such as diazepam, desmethyl diazep-
